Jonathan S. Rodríguez-Sanabria

Universidad de Guadalajara — Mexico

Medicine · Health Sciences

5h-index108citations11works1.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(5), MicroRNA in disease regulation(2), Epigenetics and DNA Methylation(2), COVID-19 Clinical Research Studies(1), Gut microbiota and health(1)

Publications11 total

Pirfenidone Prevents Myocarditis by Restoring Metabolic Hormone Levels in a Mouse MASH Model and its Effect on H9c2 Myoblast Viability under Glucolipotoxicity
Annals of Hepatology·2025Open Access
H3K9me3 demethylation by JMJD2B is regulated by pirfenidone resulting in improved NASH
Scientific Reports·2024· 5 citedOpen Access
A Novel Foodstuff Mixture Improves the Gut–Liver Axis in MASLD Mice and the Gut Microbiota in Overweight/Obese Patients
Antioxidants·2024· 4 citedOpen Access
MexMix supplementation prevented MAFLD development by restoring microbiota-gut-liver axis in a mice model.
Annals of Hepatology·2024Open Access
Pirfenidone decreases insulin, glucagon, leptin, plasminogen activator inhibitor 1, preventing nonalcoholic steatohepatitis and myocarditis in an obesity moldel
Annals of Hepatology·2024Open Access
Dietary supplementation with Mexican foods, Opuntia ficus indica, Theobroma cacao, and Acheta domesticus: Improving obesogenic and microbiota features in obese mice
Frontiers in Nutrition·2022· 7 citedOpen Access
Moringa oleifera Improves MAFLD by Inducing Epigenetic Modifications
Nutrients·2022· 20 citedOpen Access
An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease
Frontiers in Medicine·2022· 41 citedOpen Access
A Comprehensive Descriptive Epidemiological and Clinical Analysis of SARS-CoV-2 in West-Mexico during COVID-19 Pandemic 2020
International Journal of Environmental Research and Public Health·2021· 5 citedOpen Access
Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH
Scientific Reports·2021· 26 citedOpen Access
Prolonged-release pirfenidone decreases hepatic miRNAs expression in a NAFLD/NASH experimental model
Annals of Hepatology·2020Open Access

Frequent Co-authors

Juan Armendáriz‐Borunda(10), Ana Sandoval-Rodríguez(10), Rebeca Escutia-Gutiérrez(6), Arturo Santos(6), Rebeca Rosas-Campos(5), C. Alejandra Monraz-Méndez(3), Ángel Vázquez-Esqueda(3), Jesús García‐Bañuelos(2), Marina Galicia‐Moreno(2), Hugo Christian Monroy-Ramírez(2), Ricardo De la Rosa-Bibiano(2), Luis Felipe Jave‐Suárez(2), Eira Cerda‐Reyes(2), Mónica Almeida-López(2), Erika Martínez‐López(2), Luis A. Herrera(2), Natali Vega‐Magaña(2), Marcela Peña‐Rodríguez(2), J. Nuño(2), Daniel López-Cifuentes(2)